Insulcloud today announced its strategic expansion into the U.S. following FDA clearance for its Insulclock CAP smart device.

The insulin is facing supply shortages as diabetes patients increasingly turn to GLP-1 weight loss drugs such as Ozempic and ...

Insulclock CAP, which received EU approval in 2018, assists users in detecting and avoiding errors in insulin administration.

Novo has signed new partnership agreements with Dexcom, Glooko, and Roche, all of whom have technology that allows the Danish pharma to steal a march with its competitors with the launch of its ...

Counterfeit Ozempic pens, which appear to be relabelled insulin pens, have been detected in Australia and have caused a ...

Insulcloud, a pioneering healthtech company revolutionizing diabetes management, today announced its strategic expansion into the U.S. market following the FDA's clearance of its award-winning ...

This system also means that insurers end up with different rates for each drug company, so a brand of insulin that has a minimal co-pay under one insurance could cost the full list price under ...

Durban — Médecins Sans Frontières (MSF) has voiced its strong condemnation of Novo Nordisk’s recent decision to cease the ...

Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. Log out ...

"Unintended use of insulin can cause dangerously low life-threatening blood sugar levels." One Australian who used a ...